Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
A Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder (MDD)NCT04688164RLMDPhase 3Completed2022-11-01Actual
A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder CancerNCT04688931URGNPhase 3Terminated2023-03-17Actual
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ANX005 in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA)NCT04691570ANNXPhase 2Completed2023-01-17Actual
A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With IchthyosisNCT04697056Vanda PharmaceuticalsPhase 2Terminated2021-11-19Actual
A Study to Evaluate of the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Acneiform RashNCT04697069Vanda PharmaceuticalsPhase 2Terminated2021-12-13Actual
Namodenoson in the Treatment of Non-Alcoholic Steatohepatitis (NASH)NCT04697810Can-Fite BioPharmaPhase 2Unknown2025-04-15Estimated
A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 12 Weeks in Adults With Active Primary Sjögren's Syndrome (pSS)NCT04700280LKFTPhase 2Terminated2021-10-28Actual
Efficacy and Safety of ANX005 in Subjects With Guillain-Barré SyndromeNCT04701164ANNXPhase 3Completed2024-04-20Actual
A Long-Term Safety Study of BCX9930 in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)NCT04702568BioCryst PharmaceuticalsPhase 2Terminated2023-10-04Actual
Study to Evaluate the Safety, Tolerability, and Efficacy of BGE-175 in Hospitalized Adults With Coronavirus Disease 2019 (COVID-19) That Are Not in Respiratory FailureNCT04705597BIOAPhase 2Terminated2022-04-20Actual
Oral Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO DeficiencyNCT04706013MedicurePhase 3Recruiting2026-11Estimated
Study Evaluating the Efficacy and Safety of Dose Conversion From a Long-acting Erythropoiesis-stimulating Agent (Mircera®) to Three Times Weekly Oral Vadadustat for the Maintenance Treatment of Anemia in Hemodialysis SubjectsNCT04707768Akebia TherapeuticsPhase 3Completed2023-01-06Actual
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)NCT04710576Syndax PharmaceuticalsPhase 2Recruiting2023-04-07Actual
A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx in Hypertensive Participants With Uncontrolled Blood PressureNCT04714320IONSPhase 2Completed2022-06-29Actual
Atacicept in Subjects With IgA NephropathyNCT04716231VERAPhase 3Active not recruiting2025-05-15Actual
A Placebo-controlled Study of Volixibat in Subjects With Elevated Serum Bile Acids Associated With Intrahepatic Cholestasis of Pregnancy (OHANA)NCT04718961MIRMPhase 2Terminated2022-12-07Actual
Study to Evaluate ARO-APOC3 in Adults With Severe HypertriglyceridemiaNCT04720534Arrowhead PharmaceuticalsPhase 2Completed2023-03-09Actual
Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 DiseaseNCT04723537RedHill Biopharma LimitedPhase 2, Phase 3Terminated2021-12-28Actual
Open-Label Study of Setmelanotide in Hypothalamic ObesityNCT04725240RYTMPhase 2Completed2022-06-28Actual
Open Label Extension Study to Assess the Safety and Long-Term Immunogenicity of ARCT-021NCT04728347Arcturus Therapeutics, Inc.Phase 2Terminated2021-12-28Actual
A Double Masked, Placebo Controlled, Single Center, Randomized Clinical Trial to Assess the Safety and Efficacy of Subjects With Mild Asthma Induced by the Bronchial Allergen Challenge (BAC)NCT04728711ALDXPhase 2Completed2022-01-18Actual
A Study to Evaluate the Safety and Tolerability of Maralixibat in Infant Participants With Cholestatic Liver Diseases Including Progressive Familial Intrahepatic Cholestasis (PFIC) and Alagille Syndrome (ALGS).NCT04729751MIRMPhase 2Completed2024-12-17Actual
A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Clinical Trial Evaluating the Safety of Reproxalap Ophthalmic Solution in Subjects With Dry Eye DiseaseNCT04735393ALDXPhase 3Completed2022-10-11Actual
Pilot Clinical Study of CT1812 in Mild to Moderate Alzheimer's Disease Using EEGNCT04735536Cognition TherapeuticsPhase 2Completed2023-04-26Actual
Study Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung CancerNCT04736173RCUSPhase 2Active not recruiting2027-05Estimated
The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant DepressionNCT04739865COMPASS PathwaysPhase 2Completed2021-10-14Actual
An Open-Label Extension Study of STK-001 for Patients With Dravet SyndromeNCT04740476STOKPhase 2Active not recruiting2029-03-31Estimated
Trial to Investigate the Safety and Efficacy of Cannabidiol Oral Solution (GWP42003-P; CBD-OS) in Children and Adolescents With Autism Spectrum DisorderNCT04745026Jazz PharmaceuticalsPhase 2Completed2023-12-21Actual
Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-216)NCT04746911ARQTPhase 2Completed2022-05-11Actual
Onvansertib in Combination With Nanoliposomal Irinotecan, Leucovorin, and Fluorouracil for Second-Line Treatment of Participants With Metastatic Pancreatic Ductal AdenocarcinomaNCT04752696Cardiff OncologyPhase 2Completed2024-12-24Actual

Primary completion marks the end of data collection for the main study measures, not a results publication date.